Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
OTCMKTS:BXRXV

Baudax Bio (BXRXV) Stock Price, News & Analysis

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)
Free BXRXV Stock Alerts
$4.51
-1.00 (-18.15%)
(As of 11/21/2019)
Compare
Today's Range
$4.51
▼
$5.52
50-Day Range
$4.51
▼
$4.51
52-Week Range
$4.51
▼
$9.00
Volume
119,000 shs
Average Volume
53,220 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
BXRXV stock logo

About Baudax Bio Stock (OTCMKTS:BXRXV)

BXRXV Stock Price History

BXRXV Stock News Headlines

May 14, 2024 | americanbankingnews.com
Baudax Bio (OTCMKTS:BXRXV) Stock Price Down 18.1%
April 24, 2024 | investing.com
Baudax Bio Inc (BXRXQ)
March 20, 2024 | morningstar.com
Baudax Bio Inc Ordinary Shares BXRXQ
September 28, 2023 | stockhouse.com
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
August 23, 2023 | markets.businessinsider.com
Noble Financial Remains a Hold on Baudax Bio (BXRX)
June 30, 2023 | msn.com
What's Happening With Baudax Bio Shares Today
June 30, 2023 | msn.com
Baudax Bio Soars on Snapping Up Cell Therapy Developer TeraImmune
June 30, 2023 | finance.yahoo.com
Baudax Bio Acquires TeraImmune, Inc.
June 7, 2023 | benzinga.com
Baudax Bio Touts Additional Positive Data From Nerve Blocker In Surgery Patients
June 7, 2023 | technews.tmcnet.com
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
June 6, 2023 | finance.yahoo.com
Baudax Bio Announces Date of Reconvened Annual Meeting
April 27, 2023 | finanznachrichten.de
Baudax Bio, Inc.: Baudax Bio Announces Pricing of $4 Million Public Offering
April 27, 2023 | msn.com
Baudax Bio stock dips on pricing $4M stock offering at $1.15/share
April 25, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
March 27, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
January 24, 2023 | finance.yahoo.com
Why Baudax Bio Shares Trading Higher Today
January 24, 2023 | finance.yahoo.com
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
January 14, 2023 | seekingalpha.com
BXRX Baudax Bio, Inc.
December 8, 2022 | finance.yahoo.com
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
December 6, 2022 | nz.finance.yahoo.com
Baudax Bio Announces Closing of $5 Million Public Offering
December 3, 2022 | finanznachrichten.de
Baudax Bio, Inc.: Baudax Bio Announces Pricing of $5 Million Public Offering
December 2, 2022 | nz.finance.yahoo.com
Baudax Bio Announces Pricing of $5 Million Public Offering
November 30, 2022 | yahoo.com
Baudax Bio Announces 1-for-40 Reverse Stock Split
November 8, 2022 | msn.com
Baudax Bio, Inc. (BXRX) Reports Q3 Loss, Lags Revenue Estimates
September 1, 2022 | benzinga.com
Baudax Bio Announces Closing of $6.2 Million Public Offering
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BXRXV
CUSIP
N/A
CIK
N/A
Web
www.baudaxbio.com
Phone
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

BXRXV Stock Analysis - Frequently Asked Questions

How have BXRXV shares performed in 2024?

Baudax Bio's stock was trading at $4.51 on January 1st, 2024. Since then, BXRXV shares have increased by 0.0% and is now trading at $4.51.
View the best growth stocks for 2024 here.

How do I buy shares of Baudax Bio?

Shares of BXRXV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BXRXV) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
Dems have chosen Biden replacement?
Paradigm Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest